Laurent Christian, Kouanfack C., Vergne Laurence, Tardy M., Zekeng L., Noumsi N., Butel Christelle, Bourgeois Anke, Mpoudi Ngolé E., Koulla Shiro S., Peeters Martine, Delaporte Eric
Source
Emerging Infectious Diseases, 2006,
12 (6), p. 1001-1004 ISSN 1080-6040
Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.
